[ORGANIZATION]
Abbisko Therapeutics Co., Ltd.
Featured in 1 tracked story · first seen
Situations
Achondroplasia clinical trial and regulatory developments
3 clusters · 8 sources · last updated
Latest: Ascendis Pharma receives positive EU opinion for achondroplasia drug
Clinical developments for achondroplasia treatments have shown positive results across different therapeutic approaches. Abbisko Therapeutics reported preliminary Phase II data for lavengratinib (ABSK061), an oral FGFR